M.A.A.M.A.A.Al-BariM.A.A.M.A.A., Chloroquine analogues in drug discovery: new directions of uses, mechanisms of actions and toxic manifestations from malaria to multifarious diseases, „Journal of Antimicrobial Chemotherapy”, 70 (6), 2015, DOI: 10.1093/jac/dkv018, PMID: 25693996(ang.).
AndreaA.SavarinoAndreaA. i inni, Effects of chloroquine on viral infections: an old drug against today’s diseases?, „The Lancet. Infectious Diseases”, 3 (11), 2003, s. 722–727, DOI: 10.1016/s1473-3099(03)00806-5, PMID: 14592603(ang.).
Martin J.M.J.VincentMartin J.M.J. i inni, Chloroquine is a potent inhibitor of SARS coronavirus infection and spread, „Virology Journal”, 2, 2005, s. 69, DOI: 10.1186/1743-422X-2-69, PMID: 16115318, PMCID: PMC1232869(ang.).
Multicenter collaboration group of Department of Science and Technology of Guangdong Province and Health Commission of GuangdongM.D.S.T.G.P.H.C.G.ProvinceMulticenter collaboration group of Department of Science and Technology of Guangdong Province and Health Commission of GuangdongM.D.S.T.G.P.H.C.G., Expert consensus on chloroquine phosphate for the treatment of novel coronavirus pneumonia, „Chinese Journal of Tuberculosis and Respiratory Diseases”, 43, 2020, E019, DOI: 10.3760/cma.j.issn.1001-0939.2020.0019, PMID: 32075365(chiń.).
Mandeep R.M.R.MehraMandeep R.M.R. i inni, Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis, „The Lancet”, 2020, S0140673620311806, DOI: 10.1016/S0140-6736(20)31180-6, PMID: 32450107, PMCID: PMC7255293(ang.).
Mandeep R.M.R.MehraMandeep R.M.R., FrankF.RuschitzkaFrankF., Amit N.A.N.PatelAmit N.A.N., Retraction–Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis, „The Lancet”, 2020, DOI: 10.1016/S0140-6736(20)31324-6, PMID: 32485145, PMCID: PMC7260510(ang.).
M.A.A.M.A.A.Al-BariM.A.A.M.A.A., Chloroquine analogues in drug discovery: new directions of uses, mechanisms of actions and toxic manifestations from malaria to multifarious diseases, „Journal of Antimicrobial Chemotherapy”, 70 (6), 2015, DOI: 10.1093/jac/dkv018, PMID: 25693996(ang.).
AndreaA.SavarinoAndreaA. i inni, Effects of chloroquine on viral infections: an old drug against today’s diseases?, „The Lancet. Infectious Diseases”, 3 (11), 2003, s. 722–727, DOI: 10.1016/s1473-3099(03)00806-5, PMID: 14592603(ang.).
Martin J.M.J.VincentMartin J.M.J. i inni, Chloroquine is a potent inhibitor of SARS coronavirus infection and spread, „Virology Journal”, 2, 2005, s. 69, DOI: 10.1186/1743-422X-2-69, PMID: 16115318, PMCID: PMC1232869(ang.).
Multicenter collaboration group of Department of Science and Technology of Guangdong Province and Health Commission of GuangdongM.D.S.T.G.P.H.C.G.ProvinceMulticenter collaboration group of Department of Science and Technology of Guangdong Province and Health Commission of GuangdongM.D.S.T.G.P.H.C.G., Expert consensus on chloroquine phosphate for the treatment of novel coronavirus pneumonia, „Chinese Journal of Tuberculosis and Respiratory Diseases”, 43, 2020, E019, DOI: 10.3760/cma.j.issn.1001-0939.2020.0019, PMID: 32075365(chiń.).
Mandeep R.M.R.MehraMandeep R.M.R. i inni, Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis, „The Lancet”, 2020, S0140673620311806, DOI: 10.1016/S0140-6736(20)31180-6, PMID: 32450107, PMCID: PMC7255293(ang.).
Mandeep R.M.R.MehraMandeep R.M.R., FrankF.RuschitzkaFrankF., Amit N.A.N.PatelAmit N.A.N., Retraction–Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis, „The Lancet”, 2020, DOI: 10.1016/S0140-6736(20)31324-6, PMID: 32485145, PMCID: PMC7260510(ang.).
